Annotation
The high contagiousness of the latest strains of Covid-19 qualitatively changes the behavior of the “virus vs human” system. Numerical experiments with a model of the Covid-19 epidemic in Moscow have shown that a reproduction number R0 of about 4 is critical, defining a qualitative change in the dynamics of the epidemic. Below this value (observed until 2022), the long-term forecast tends to undamped oscillations; above this value, it is described by damped oscillations: amplitudes of the epidemic waves get smaller and smaller, with a constant, very high background level of morbidity (or high-intensity vaccination) that maintains the state of natural immunity at a level close to 100% (reaching 93.7% for the current R0 value of about 16). At the limit, the system tends to a stable equilibrium point. Here we consider a reduced model of epidemic dynamics. Its study (search for equilibrium solutions, analysis of their stability, construction a bifurcation diagram and a phase portrait) confirms the presence of points of qualitative change in the behavior of the “virus vs human” system (bifurcation points). Some practical results for Moscow are given. A further increase in the contagiousness of the virus does not change the picture significantly, thus more infectious strains are not to be feared. The key parameter of the study is the function of the immunity level depending on the time after the disease. The damping of omicron waves (oscillations), observed recently in many countries, is a confirmation of the correctness of the accepted hypotheses.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was carried out with the financial support of the Russian Scientific Foun-dation within the framework of the scientific project (grant) 22-11-00317
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
